Thrivent Financial for Lutherans
CLX icon

Thrivent Financial for Lutherans’s Clorox CLX Stock Holding History

Thrivent Financial for Lutherans’s Portfolio CLX Stock Details CLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$498K Sell
4,806
-3,501
-42% -$397K ﹤0.01% 2221
2025
Q4 		$838K Sell
8,307
-55
-0.7% -$5.97K ﹤0.01% 2029
2025
Q3 		$1.03M Buy
8,362
+1,166
+16% +$145K ﹤0.01% 1765
2025
Q2 		$864K Sell
7,196
-530
-7% -$70.7K ﹤0.01% 1875
2025
Q1 		$1.14M Sell
7,726
-743
-9% -$113K ﹤0.01% 1635
2024
Q4 		$1.38M Sell
8,469
-622
-7% -$102K ﹤0.01% 1691
2024
Q3 		$1.48M Buy
9,091
+236
+3% +$35K ﹤0.01% 1659
2024
Q2 		$1.21M Buy
8,855
+709
+9% +$98.5K ﹤0.01% 1751
2024
Q1 		$1.25M Buy
8,146
+73
+0.9% +$10.9K ﹤0.01% 1761
2023
Q4 		$1.15M Sell
8,073
-17,947
-69% -$2.39M ﹤0.01% 1751
2023
Q3 		$3.41M Sell
26,020
-16,362
-39% -$2.49M 0.01% 970
2023
Q2 		$6.74M Buy
42,382
+36,853
+667% +$5.94M 0.02% 749
2023
Q1 		$875K Buy
5,529
+19
+0.3% +$2.85K ﹤0.01% 1860
2022
Q4 		$773K Buy
5,510
+31
+0.6% +$4.4K ﹤0.01% 1896
2022
Q3 		$703K Buy
5,479
+55
+1% +$7.94K ﹤0.01% 1893
2022
Q2 		$765K Buy
5,424
+18
+0.3% +$2.57K ﹤0.01% 1860
2022
Q1 		$752K Sell
5,406
-20,095
-79% -$3.08M ﹤0.01% 1986
2021
Q4 		$4.5M Sell
25,501
-844
-3% -$141K 0.01% 934
2021
Q3 		$4.51M Sell
26,345
-16,494
-39% -$2.84M 0.01% 936
2021
Q2 		$7.71M Sell
42,839
-10,064
-19% -$1.84M 0.02% 771
2021
Q1 		$10.2M Buy
52,903
+2,693
+5% +$518K 0.02% 655
2020
Q4 		$10.1M Sell
50,210
-2,958
-6% -$612K 0.02% 644
2020
Q3 		$11.2M Buy
53,168
+34,997
+193% +$7.79M 0.03% 562
2020
Q2 		$3.91M Buy
18,171
+10,548
+138% +$2.11M 0.01% 790
2020
Q1 		$1.32M Buy
7,623
+852
+13% +$141K ﹤0.01% 1150
2019
Q4 		$1.04M Buy
6,771
+997
+17% +$149K ﹤0.01% 1452
2019
Q3 		$877K Hold
5,774
– – ﹤0.01% 1500
2019
Q2 		$884K Buy
5,774
+50
+0.9% +$7.64K ﹤0.01% 1490
2019
Q1 		$918K Buy
5,724
+64
+1% +$9.93K ﹤0.01% 1434
2018
Q4 		$872K Buy
5,660
+99
+2% +$15.4K ﹤0.01% 1244
2018
Q3 		$836K Buy
5,561
+123
+2% +$17.5K ﹤0.01% 1402
2018
Q2 		$735K Buy
5,438
+57
+1% +$7.04K ﹤0.01% 1454
2018
Q1 		$716K Buy
5,381
+113
+2% +$15.2K ﹤0.01% 1427
2017
Q4 		$784K Sell
5,268
-17
-0.3% -$2.31K ﹤0.01% 1399
2017
Q3 		$697K Buy
5,285
+360
+7% +$48.4K ﹤0.01% 1373
2017
Q2 		$656K Sell
4,925
-37,910
-89% -$5.12M ﹤0.01% 1358
2017
Q1 		$5.77M Buy
42,835
+38,270
+838% +$4.96M 0.03% 536
2016
Q4 		$548K Buy
4,565
+240
+6% +$28.3K ﹤0.01% 1465
2016
Q3 		$541K Buy
4,325
+230
+6% +$30.1K ﹤0.01% 1422
2016
Q2 		$566K Buy
4,095
+285
+7% +$37K ﹤0.01% 1362
2016
Q1 		$480K Buy
3,810
+190
+5% +$24.2K ﹤0.01% 1383
2015
Q4 		$459K Buy
3,620
+70
+2% +$8.69K ﹤0.01% 1383
2015
Q3 		$410K Buy
3,550
+100
+3% +$11.2K ﹤0.01% 1294
2015
Q2 		$359K Buy
3,450
+200
+6% +$21.6K ﹤0.01% 1308
2015
Q1 		$359K Buy
3,250
+200
+7% +$21.7K ﹤0.01% 1282
2014
Q4 		$318K Buy
3,050
+100
+3% +$10K ﹤0.01% 1352
2014
Q3 		$283K Sell
2,950
-100
-3% -$9.04K ﹤0.01% 1395
2014
Q2 		$279K Sell
3,050
-50
-2% -$4.48K ﹤0.01% 1435
2014
Q1 		$273K Hold
3,100
– – ﹤0.01% 1290
2013
Q4 		$288K Hold
3,100
– – ﹤0.01% 1289
2013
Q3 		$253K Sell
3,100
-132,538
-98% -$11.2M ﹤0.01% 1323
2013
Q2 		$11.3K Buy
+135,638
New +$11.7M 0.07% 281

Other funds holding CLX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $147M AUM 25.76% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Thrivent Financial for Lutherans's CLX Position: Q1 2026 in Review

Thrivent Financial for Lutherans reduced its Clorox (CLX) stake by 42% in Q1 2026, selling an estimated $397K and leaving 4,806 shares worth $498K. The position accounts for ﹤0.01% of the portfolio, ranked #2221.

Thrivent Financial for Lutherans first reported a position in CLX in Q2 2013 and has held it in 52 quarters since. The position peaked at $11.2M in Q3 2020. 1,082 funds tracked by Wall St. Rank hold CLX as of Q1 2026.

  • Thrivent Financial for Lutherans held 4,806 shares of Clorox worth $498K as of Q1 2026.
  • Thrivent Financial for Lutherans sold 3,501 Clorox shares in Q1 2026, an estimated $397K.
  • Clorox made up ﹤0.01% of Thrivent Financial for Lutherans's portfolio in Q1 2026, its #2221 holding.
  • Thrivent Financial for Lutherans first reported a position in Clorox in Q2 2013 and has held it in 52 quarters since.
  • Thrivent Financial for Lutherans's Clorox position peaked at $11.2M in Q3 2020.
  • 1,082 funds tracked by Wall St. Rank held Clorox as of Q1 2026.

Based on Thrivent Financial for Lutherans's 13F filing for Q1 2026, filed 1 May 2026.